A study for a 22 year old woman who takes Terbinafine Hydrochloride - from FDA reports


285 females aged 22 (±5) who take the same drug are studied. This is a personalized study for a 22 year old female patient who has Fungus On Toes. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 25, 2017

285 females aged 22 (±5) who take Terbinafine Hydrochloride are studied.

Number of reports submitted per year:

Terbinafine Hydrochloride for a 22-year old woman.

Information of the patient in this study:

  • Age: 22
  • Gender: female
  • Conditions: Fungus On Toes
  • Drugs taken:
    • Terbinafine Hydrochloride (terbinafine hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Anemia: 0 (0% of females aged 22 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • rashes
  • urticaria
  • fever
  • acute generalised exanthematous pustulosis
  • joint swelling
  • eye swelling
  • dizziness
  • skin exfoliation
  • musculoskeletal stiffness
  • purpura
1 - 6 months:
  • drug ineffective
  • alanine aminotransferase increased
  • ageusia
  • blood creatine phosphokinase increased
  • aspartate aminotransferase increased
  • rashes
  • weight decreased
  • gastroesophageal reflux disease
  • itching
  • drug exposure during pregnancy
6 - 12 months:
  • abdominal pain upper
  • cholecystitis chronic
  • xanthopsia
  • white blood cell count decreased
  • gallstones
  • gallbladder cholesterolosis
  • upper respiratory tract infection
  • blood bilirubin increased
  • nausea and vomiting
  • injury
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
  • abortion induced
  • drug exposure during pregnancy
not specified:
  • drug ineffective
  • rashes
  • itching
  • nausea
  • pain
  • gallstones
  • depression
  • vaginal bleeding between periods
  • abdominal pain
  • injury

Top conditions involved for these people *:

  • Nail Tinea (44 people, 15.44%)
  • Birth Control (15 people, 5.26%)
  • Depression (10 people, 3.51%)
  • Pain (8 people, 2.81%)
  • Jock Itch (4 people, 1.40%)

Top co-used drugs for these people *:

  • Yaz (16 people, 5.61%)
  • Yasmin (14 people, 4.91%)
  • Hydrocodone Bitartrate And Acetaminophen (8 people, 2.81%)
  • Fluoxetine (8 people, 2.81%)
  • Ibuprofen (7 people, 2.46%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Anemia (less than the normal quantity of haemoglobin in the blood) has been reported by people with thyroid diseases, systemic sclerosis (scleroderma) (latest reports from 741 Anemia patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Terbinafine hydrochloride, Fungus on toes Anemia

You may be interested in these posts

More posts for: Terbinafine hydrochloride, Fungus on toes Anemia